Navigation Links
Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial
Date:5/1/2009

s. The primary objective of the trial was to demonstrate that the frequency of wound infection and the frequency of reoperation due to burst-abdomen after primary median laparotomy for elective surgical intervention are equal or lower than in previously reported clinical trials.

Dr. Simon Williams, President and CEO of Tepha, commented, "We are pleased to witness the launch of the MonoMax product and look forward to continued collaboration with our partner Aesculap on additional products based on our TephaFLEX technology".

About Aesculap AG

Aesculap, a Tepha corporate partner since 2004, introduced the MonoMax product to customers at a symposium held in conjunction with the German Surgical Congress in Munich and will be commercializing the product in Europe commencing with Germany immediately following the congress. Based in Germany and Spain, Aesculap is a division of B. Braun Melsungen AG, focused on products for core processes in operative medicine. Aesculap's product range includes sutures, implants for orthopedic and spinal surgery, surgical instruments, endoscopes, surgical motor systems, container and storage systems, and vascular therapy products.

About Tepha, Inc.

Tepha, Inc, is a developer of medical devices derived from a new class of resorbable polymers that have been engineered utilizing recombinant DNA technology. The unique biologic and mechanical properties of the Tepha PHA polymers has been recognized by an expanding list of corporate partners that now includes Aesculap AG, ENTrigue Surgical, HemCon Medical Technologies, NMT Medical (Nasdaq: NMTI), and Tornier, Inc. Tepha received its first FDA 510(k) clearance for its TephaFLEX(R) Absorbable Suture in February, 2007 and the Company and its partners have now received six 510(k)'s covering a range of medical
'/>"/>

SOURCE Tepha, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Dr Stephan Rietiker Joins BioCeramic Therapeutics
2. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
3. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
4. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
5. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
6. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
7. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
8. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
10. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
11. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... (PRWEB) July 10, 2014 Understanding the ... channel-expressing cell lines, and the gap that currently exists ... that expand its industry-leading portfolio of validated ion channel ... ion channel-expressing cell lines, as ion channels control many ... control this activity creates the potential to treat a ...
(Date:7/10/2014)... July 10, 2014 Robert Harman, DVM, Founder ... company, is proud to announce the relaunch of his highly ... a new series called “ What are Stem Cells ?” ... honest and straightforward foundation in the basics of stem cell ... on the right type of treatment when considering regenerative medicine. ...
(Date:7/10/2014)... July 10, 2014 Senior supply chain ... professional associations, addressed the challenges of “Reducing Cost, Lead ... Industries” through strategic sourcing. Describing the partnership of the ... Supply Chain Management Institute ( SCMI) of the ... June 24 at the Kroc Institute of Peace and ...
(Date:7/10/2014)... 10, 2014  Kainos Capital, a firm specializing in ... that it has acquired the Slim-Fast brand from Unilever. ... Terms of the transaction were not disclosed. ... business that markets ready-to-drink shakes, powders, bars and snacks ... and in the United Kingdom ...
Breaking Biology Technology:Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 2Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 3Biotech & Biopharm Supply Chain Management Executives Launch BSMA in San Diego 4Kainos Capital Acquires Slim-Fast From Unilever 2
... genetics,(Nasdaq: DCGN ) today expressed its enthusiastic ... bill that, many years in the,making, is now ... be signed,promptly by President Bush. GINA would provide ... prohibiting discrimination against,individuals in matters of employment or ...
... April 25 Beckman,Coulter, Inc. (NYSE: BEC ... a quarterly dividend payout of seventeen cents ($0.17) ... 23, 2008 to all stockholders of,record on May ... payout of dividends., (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ), ...
... BERLIN, April 25 Processes and products based ... the chemical industry in a wide range of ... the field of industrial,biotechnology in Germany will be ... Bioprocessing (April 27-30, 2008) in Chicago, Illinois.,The panel ...
Cached Biology Technology:deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information 2deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information 3deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information 4World Congress on Industrial Biotechnology: Germany Home to Top Biotech Research and Investment 2
(Date:7/10/2014)... stabilize or even improve the state of fisheries ... in the Mediterranean has deteriorated over the past ... fish species reported in the Cell Press journal ... call for stringent monitoring of Mediterranean fishing activities, ... plans in Mediterranean waters. , Their data show ...
(Date:7/10/2014)... Poor peepers are a problem, even if you are ... an imperious predator, scouring the shallow waters for any ... eye exam by Yale University scientists, you,re reduced to ... night. , Such is the lot of the giant ... new paper by Yale paleontologists, published in the journal ...
(Date:7/10/2014)... controversy centres around a family of enzymes known as ... group in their active site. At the centre of ... becomes oxidised (ferryl) when a reacting heme is in ... has remained unanswered for decades is whether this oxidation ... group (OH). Resolving this fundamental question has implications for ...
Breaking Biology News(10 mins):Mediterranean fish stocks show steady decline 2Extinct sea scorpion gets a Yale eye exam, with surprising results 2Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3
... record of oxygen concentration in the earth's atmosphere shows that ... gave mammals the evolutionary boost they needed to dominate the ... and lead author of a paper published Sept. 30 ... have measured the abundance of carbon 13, a byproduct ...
... have learned how to selectively shut down a flyweight-sized ... that may help doctors better understand cancer, birth defects ... be reported this week in the online Proceedings of ... of genetic material called microRNAs. , Once thought to ...
... A team of researchers from the Department of Biochemistry ... the Universitat Autònoma de Barcelona has discovered that tetanus ... a therapy against psychological disorders such as depression, anxiety ... disorders such as Parkinson's disease. , Tetanus toxin is ...
Cached Biology News:Oxygen increase caused mammals to triumph, researchers say 2Micro-molecule plays big role in birth defects 2Tetanus toxin found to have therapeutic properties 2
...
...
...
... is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has long ... new radiolabeled ligands selected to keep pace ... range of products and services for receptor ... state-of-the-art radioligands. If you do not find ...
Biology Products: